NGD Care Myco Immune Complex: Product Profile

NGD Care Myco Immune Complex is a named branded product for Dogs and cats; manufacturer positioning must be kept separate from independent clinical evidence.

Liposomal oral capsules; current official page lists a 400 mg capsule. Intended species: Dogs and cats.

Per current official page: 75 mg Agaricus blazei Murill, 75 mg Maitake (Grifola frondosa), 75 mg Shiitake (Lentinula edodes), and 75 mg Coriolus versicolor, plus sunflower lecithin, maltodextrin, and a hydroxypropyl methylcellulose vegetable capsule; marketed with Lipodry liposomal technology.

NGD Care markets the four-mushroom liposomal combination for immune support, recovery, and adjunctive discussion during cancer care. It claims enhanced absorption from liposomal formulation. These are manufacturer statements and require finished-product pharmacokinetic and clinical evidence before being treated as established.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

The official page refers to beta-glucan mechanisms and canine Coriolus studies, but no controlled veterinary oncology trial of this finished four-mushroom liposomal product was identified. A study of another PSP extract cannot establish equivalence. Claims of “significantly” greater bioavailability also require direct comparative product data; none was located in the reviewed official material.

The manufacturer warns about mushroom hypersensitivity, autoimmune disease, immunosuppressants, possible mild nausea or stool change, and theoretical immune, anticoagulant, antiplatelet, and metabolic interactions. In cancer care, also review immunotherapy, corticosteroids, surgery, bleeding, liver or kidney disease, pregnancy, and other mushrooms. The current physical veterinary label takes precedence over website prose.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Marketed from the Netherlands as an orthomolecular/liposomal animal supplement. The exact national feed registration or veterinary-medicine authorization status was not located in a public competent-authority source during this review; it should not be described as an approved anticancer medicine.

Netherlands; European Union

Record capsule version, lot, expiry, ingredient panel, start date, and supportive objective. Follow appetite, nausea, vomiting, stool, skin signs, energy, weight, and treatment adherence. Ask the veterinarian whether blood counts, chemistry, coagulation, or therapy-specific monitoring should change. Preserve objective disease follow-up and avoid treating vitality as a tumor endpoint.